TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05413525

Intervention type: PROCEDURE
Intervention: ultrasound-guided manual vacuum aspiration (USG- MVA)
Description: USG-MVA was carried out as an outpatient day procedure. Women was given a 400μg oral misoprostol tablet 2-3 hours before the procedure. All patients will be given 500mg naproxen orally an hour before the procedure. During the USG-MVA, all the women were placed in the lithotomy position and aseptically dressed. Speculum was performed to visualize the cervix with PCB performed. USG-MVA was performed using a 60ml charged syringe with a flexible curetteattached to it. Transabdominal USG during MVA was performed. During the procedure, local lidocaine gelwas applied to the cervical canal and over the end of the MVA catheter tip during the insertion.The USG-MVA was stopped as soon as USG confirmed that the uterine cavity was empty, defined as a thin endometrial lining with no evidence of retained products of conception.
Study: NCT05124106

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Raman Spectrometry
Description: Bladder tumor is examined with Raman spectrometry during endoscopy
Study: NCT05046522

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide sold as Levagen +
Description: Investigational product to be taken as a 700mg (2 x 350mg) dosage at onset of migraine. If unresolved at 2 hours post onset of migraine, a second dose of 700mg (2 x 350mg) is to be taken.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo comparator - maltodextrin and microcrystalline cellulose mix
Description: Placebo product to be taken as a 700mg (2 x 350mg) dosage at onset of migraine. If unresolved at 2 hours post onset of migraine, a second dose of 700mg (2 x 350mg) is to be taken.
Study: NCT05798039

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ENRICH
Description: Participants will receive additional heart health-focused materials and guidance in sessions with their nurse home visitor. The nurse will help them choose and work towards behavior goals to support their health. This will include goals for activity, diet, weight, blood pressure, diabetes, smoking, social relationships, sleep, parenting, and getting health care.
Study: NCT05347966

Intervention type: OTHER
Group type: OTHER
Intervention: Brain Health PRO
Description: BHPro is a 45-week, multidomain web-based formal educational program which has been designed to increase dementia literacy, convey best available evidence for lifestyle changes that can mitigate dementia risk, and foster engagement toward one's own brain health.
Study: NCT06019195

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Time restricted eating
Description: not more than 10 hrs. eating window daily goal for 6 months
Study: NCT05470881

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropine Sulfate
Description: Administration of one drop QD on both eyes for 14 days.
Study: NCT05287698

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold vapor
Description: Before surgery, socio-demographic data of the patients, ASA and Mallampati scores, sore throat level, and dysphagia level will be recorded. After surgery, patients will be evaluated in the recovery room for their suitability to participate in the study with the Ramsay sedation scale and the Modified Aldrete Scale. Cold vapor will be applied to the patients for 15 minutes in the recovery room during the postoperative period. The parameters to be set on the device for the cold vapor to be applied to the patients in the early postoperative period will be vapor intensity level 5, air blowing intensity 5, heater intensity 1 (+10C), and timer 15 minutes. The patients will be evaluated by the researchers in terms of sore throat and dysphagia before and 15 minutes after the cold vapor application in the recovery room and at the 6th, 12th, and 24th hours after the cold vapor application in the postoperative service.
Study: NCT05508386

Intervention type: OTHER
Group type: OTHER
Intervention: MATLAB-based interface, showing 50 EEG traces, classification of the EEG-pattern as Burst Suppression possible, yes, no.
Description: A software environment (MATLAB) was developed, that allows the international experts to access the data set and score the traces pseudonymously. This MATLAB-based interface shows 50 EEG traces. A representative dataset was composed, consisting of definite Burst Suppression patterns (positive control), intraoperative EEG without Burst Suppression patterns (negative control), and patterns indicating different manifestations of a possible Burst Suppression-like pattern.
Study: NCT06009640

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intraoperative neurophysiological monitoring with Nicolet Endeavor IOM Machine
Description: Integration of intraoperative neurophysiological monitoring (IONM) into laparoscopic decompression surgery to protect pelvic nerves by continuously monitoring when they are at risk during surgery.
Study: NCT05019274

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Culinary Medicine Intervention
Description: Participants randomized to the Culinary Medicine intervention will complete a series of 6 virtual culinary medicine cooking classes (1 class per month for 6 months). Virtual sessions will be delivered via Zoom using a combination of large group instruction and small group break-out sessions in which participants prepare a recipe in their home kitchen with the virtual assistance from trained group facilitators. After preparing the dish, participants will enjoy the dish they prepared and report-back to the large group about their dish and experience. Classes will be conducted in English and Spanish with language-concordant instructors and facilitators.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care Nutrition Visits
Description: Participants randomized to standard of care nutrition visits will complete a series of 6 nutrition visits (1 session per month for 6 months) led by bilingual (English/Spanish) dieticians. Sessions will consist of a mix of individual and small group sessions per standard of care in the clinic.
Study: NCT06013501

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: puppet show
Description: puppet show to the child before and during subcutaneous application
Study: NCT04762485

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Humanized CD7 CAR-T cells
Description: Split intravenous infusion of CD7 CAR-T cells \[dose escalating infusion of (0.5-10)x10\^6 CD7 CAR-T cells/kg
Study: NCT05733143

Intervention type: OTHER
Intervention: cardiopulmonary exercise stress test (CPEST)
Description: The study is observational and purely exploratory. We will utilise cardiopulmonary exercise stress testing to assess levels of fitness and causes for symptoms in proposed groups.

Intervention type: OTHER
Intervention: cardiopulmonary exercise stress test (CPEST)
Description: The study is observational and purely exploratory. We will utilise cardiopulmonary exercise stress testing to assess levels of fitness and causes for symptoms in proposed groups.

Intervention type: OTHER
Intervention: cardiopulmonary exercise stress test (CPEST)
Description: The study is observational and purely exploratory. We will utilise cardiopulmonary exercise stress testing to assess levels of fitness and causes for symptoms in proposed groups.

Intervention type: OTHER
Intervention: cardiopulmonary exercise stress test (CPEST)
Description: The study is observational and purely exploratory. We will utilise cardiopulmonary exercise stress testing to assess levels of fitness and causes for symptoms in proposed groups.
Study: NCT06328816

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: routine rehabilitation treatment
Description: The routine rehabilitation treatment included intervention for risk factors (such as blood pressure, blood lipids, and blood glucose control, restriction of smoking and alcohol, exercise, etc.) Besides, the patients with stable vital signs were scheduled for specialized rehabilitation training upon enrollment, and targeted rehabilitation programs were selected, conducted by experienced rehabilitation therapists.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: routine rehabilitation treatment
Description: The routine rehabilitation treatment included intervention for risk factors (such as blood pressure, blood lipids, and blood glucose control, restriction of smoking and alcohol, exercise, etc.) Besides, the patients with stable vital signs were scheduled for specialized rehabilitation training upon enrollment, and targeted rehabilitation programs were selected, conducted by experienced rehabilitation therapists.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computer-assisted Cognitive Function Training
Description: Based on the patient's cognitive impairment assessment results, the training content includes Attention game training, Executive function program training, Logical reasoning training, Agility training, Memory training. The training is conducted seven days a week, once a day, for a duration of 30-45 minutes per session
Study: NCT05899023

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telehealth Bridge Visits
Description: Patients will be scheduled for a telemedicine visit staffed by a family or internal medicine trained physician who will assess their understanding and answer any questions about the new diagnosis of diabetes, start initial conversations about how to improve their habits around diet and exercise, and discuss medication options for diabetes and, if appropriate, initiate treatment. At the end of the telemedicine visit, providers will attempt to address any difficulties that patients are experiencing in accessing primary care by providing an alternative contact for care or reaching out to a primary care doctor as necessary. If the patient experiences difficulties accessing a primary care provider based on their first telemedicine visit, then an additional telemedicine visit can be scheduled for the patient.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Standard of care currently includes calls from the site's follow-up center to see if patients received their HbA1c result, understood what their result meant, had any problems accessing medications prescribed or any difficulty scheduling an outpatient follow-up visit.
Study: NCT04949646

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Intraoperative Neuromonitoring
Description: Pelvic Intraoperative Neuromonitoring (pIONM) allows mapping of the pelvic autonomous plexus during total mesorectal excision (TME).
Study: NCT05083325

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oseltamivir 75mg Test Drug capsules
Description: Investigational Medicinal Product

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oseltamivir 75mg capsules Reference Product capsules
Description: Tamiflu (Roche Pharma (Switzerland) AG, Basel)
Study: NCT05897801

Intervention type: DIAGNOSTIC_TEST
Intervention: MeMed BV®
Description: One blood sampling of 3ml will be drawn on the first day for the performance of the MeMed BV® test. Two rectal swabs will be taken for determining the MDRO gut colonization. Patient information regarding the specific respiratory tract infection and the treatment regimen being prescribed will be recorded in the eCRF made specifically for this trial.
Study: NCT05661721

Intervention type: OTHER
Group type: OTHER
Intervention: Sweet licorice
Description: Ecologic, vegan and gluten free, low-sodium sweet licorice pastilles made from Glycyrrhiza glabra, with a manufacturer specified content of 4% sugars, 2% glycyrrhizin and 0.03% salt, will be used as intervention. The exact glycyrrhizin content will be determined before the study begins, and participants will be instructed to consume a daily licorice dose that is equivalent to 100 mg of glycyrrhizin.

Intervention type: OTHER
Group type: OTHER
Intervention: Sweet licorice
Description: Ecologic, vegan and gluten free, low-sodium sweet licorice pastilles made from Glycyrrhiza glabra, with a manufacturer specified content of 4% sugars, 2% glycyrrhizin and 0.03% salt, will be used as intervention. The exact glycyrrhizin content will be determined before the study begins, and participants will be instructed to consume a daily licorice dose that is equivalent to 100 mg of glycyrrhizin.

Intervention type: OTHER
Group type: OTHER
Intervention: Salty licorice
Description: A vegan and gluten free salty licorice without glycyrrhizin, flavored with ammonium chloride, with a manufacturer specified content of 0% sugars and 0.05% salt, will be used as control. The amount of salty licorice will be the same as for sweet licorice, and thus determined after the glycyrrhizin content analysis of the sweet licorice.

Intervention type: OTHER
Group type: OTHER
Intervention: Salty licorice
Description: A vegan and gluten free salty licorice without glycyrrhizin, flavored with ammonium chloride, with a manufacturer specified content of 0% sugars and 0.05% salt, will be used as control. The amount of salty licorice will be the same as for sweet licorice, and thus determined after the glycyrrhizin content analysis of the sweet licorice.
Study: NCT06103084

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bahgina
Description: Bahgina, a locally produced cereal based food, will be provided at 200g/day/child for a duration of six months on top of the routine nutrition services provided by the local government and nutrition partners.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: SQLNS
Description: Small quantity lipid based nutrient supplement (SQ-LNS) will be provided at 20g/day/child for a duration of six months on top of the routine nutrition services provided by the local government and nutrition partners.
Study: NCT05313750

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: anti-infective therapy sitafloxacin
Description: anti-infective therapy

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: anti-infective therapy levofloxacin
Description: anti-infective therapy
Study: NCT05741099

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Umbilical cord mesenchymal stem cells implantation
Description: Patient in Mscs group will receive MSCs implantation by intravenous injection.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Comparator
Description: Patients in comparator group will receive placebo treatment
Study: NCT05389111

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Internal discourses
Description: This intervention will take place following the randomization performed at the V1 visit. It will be held in videoconference, will be led by a professional of the training field, specialist of the trail activity and trained in the use of mental strategies

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Non internal discourses
Description: This intervention will take place following the randomization performed at the V1 visit. It will be held in videoconference, and will be conducted by a professional of the training field, specialist of the trail activity and coach of mountain guide
Study: NCT06310902

Intervention type: DIAGNOSTIC_TEST
Intervention: Single-cell Sequencing Analysis
Description: Identification of rare cell populations, the characterization of cell types and subtypes, and the discovery of novel cell states.

Intervention type: DIAGNOSTIC_TEST
Intervention: Single-cell Sequencing Analysis
Description: Identification of rare cell populations, the characterization of cell types and subtypes, and the discovery of novel cell states.
Study: NCT04503096

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High-dose accelerated rTMS
Description: A MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System will be utilized. All participants will receive open-label treatment for approximately eight, 3-minute sessions of intermittent theta burst rTMS on each of three days within an eight-day span. A single session = 600 pulses at 120% resting motor threshold (rMT), intermittent Theta Burst Stimulation (iTBS) triplets at 50 Hz for 2 seconds and repeated every 10 seconds for a total of 190 s to left dorsolateral prefrontal cortex. Total pulses = 14,400. To enable adherence and retention, the days do not need to be contiguous. Same day sessions will be separated by 10-15 minutes, but more accounting for participant comfort.
Study: NCT04033263

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Mouth rinse 1
Description: Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mouth rinse 2
Description: Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mouth rinse 3
Description: Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mouth rinse 4
Description: Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.
Study: NCT04935918

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ACT
Description: Implantation of ACT balloon, Uromedica (Irvine, CA, USA) periurethrally at the bladder neck. The ACT system is a permanent implant designed for the correction of incontinence in patients.
Study: NCT05518877

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: Administration of Ketamine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: Administration of Ketamine
Study: NCT05923398

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Intervention Group
Description: Participants will use a Digital Intervention Suite composed of a virtual reality (VR) scenario, a web-based platform, and a wearable device to assess their stress response in near-real time and in a hypothetical stressful scenario.~During the VR scenario, physiological signals such as Galvanic Skin Response (GSR), Electrocardiogram (ECG), Respiratory Independence (RI), and Photoplethysmography will be measured. Additionally, an educational intervention video on how to deal with stress and distress will be shown to participants. We will then request participants to practice the skills taught during the intervention video in the VR scenario.~The wearable device (Oura Ring) will measure sleep, activity, readiness information, heart rate, heart rate variability, body temperature (delta), and respiratory rate. Additionally, the web-based platform will, through questionnaires, assess stress-related symptoms such as loneliness, anxiety, depression, and moral injury.
Study: NCT04033263

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mouth rinse 5
Description: Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mouth rinse 6
Description: Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mouth rinse 7
Description: Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mouth rinse 8
Description: Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mouth rinse 9
Description: Participants will use 10mL of the respective mouth rinse, swish in the mouth for 30 seconds and spit it out. This will be made twice a day, for a total of 5 days.
Study: NCT05839353

Intervention type: OTHER
Intervention: SBAR training by serious game
Description: SBAR training by serious game
Study: NCT06262945

Intervention type: DRUG
Intervention: Analgesic
Description: Analgesics are prescribed for the patients.

Intervention type: DRUG
Intervention: Analgesic
Description: Analgesics are prescribed for the patients.
Study: NCT05811039

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remo-Wax® Oil
Description: Remo-Wax® Oil (abbreviated RWO; GMDN (Global Medical Device Nomenclature) code 46259, Earwax softening oil), is a CE-marked, non-sterile fluid mixture, used for prevention of impacted earwax. Remo-Wax® Oil also moisturizes the skin in the ear canal and reduces itching and irritation caused by the ear canal dryness
Study: NCT04788953

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Solriamfetol Oral Tablet
Description: The administered drug is SUNOSI (solriamfetol) tablets for oral use. Initial U.S. Approval: 2019

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Control subjects will receive placebo tablets for oral use.
Study: NCT05733962

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of the device DBL-4pen
Description: During the treatment period, the patient will use~* the DBL-4pen device (consisting of a software hosting the Diabeloop algorithm installed on a smartphone)~* the associated device #1: Dexcom G6, Continuous Glucose Monitoring (CGM)~* the associated device #2: Two Mallya caps for their rapid- and long-acting insulin pens.~The regulation algorithm hosted by DBL-4pen software recommends insulin doses to be administrated by the patient.
Study: NCT06262945

Intervention type: DRUG
Intervention: Analgesic
Description: Analgesics are prescribed for the patients.
Study: NCT06450717

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Khymeia VRRS
Description: VRRS is an electronic device for remote rehabilitation of cognitive (e.g., memory, attention, spatial perception, logical-mathematical skills, language, executive functions...) and motor (gross and fine motor skills) functions. It can be used in on-line and off-line mode at home, and the exercises are chosen by the therapist according to the patient's specific difficulties and needs from a cognitive and motor library.
Study: NCT05224635

Intervention type: PROCEDURE
Intervention: Vascular Injury
Description: The Society of Vascular Surgery has established a robust vascular disease registry but this organization's focus is on vascular disease and lacks capture of the data points necessary to discern trauma-specific outcomes. Recent military experience from the United States and United Kingdom, including the Balad Vascular Registry and the Global War on Terror (GWOT) Vascular Registry have provided a contemporary assessment of wartime vascular injury, but again these studies have been retrospective case series and registry reviews. Furthermore, applications of lessons learned in wartime vascular injury do not completely translate to management in trauma centers in the United States.